Imalux Awarded $2.3 Million Research Grant

Entities Mentioned

• Imalux
• Bill R. Sanford
• Imalux Niris

1. CLEVELAND--(BUSINESS WIRE)--Imalux Corporation (“Imalux”), a medical device company and developer of the Niris™ Imaging System based on Optical Coherence Tomography (“OCT”) technology, today announced the receipt of a Fast-Track research grant from the National Cancer Institute of the National Institutes of Health. The award of up to $2.3 million is to fund Imalux’s accelerated development of video rate Optical Coherence Tomography for early stage cancer visualization.
   
   The Phase 1 funding of the grant in the amount of $322,000 is in place for the first year of the project. Assuming satisfactory achievement of the Phase ... (Read Full Article)
   
   

   Related Articles

   • GlucoLight Corporation Raises Second Tranche of ''c'' Round Financing
   • also categorized in Funding
   • OCTANe Foundation for Innovation Grants $20,000 Innovation Award
   • also published in businesswire.com
   • OCT market to top $800 million by 2012
   • also categorized in Funding
   • GlucoLight Corporation Raises Second Tranche of “c” Round Financing
   • also categorized in Funding
   • Optical Coherence Tomography Market to Top $800 Million by 2012
   • also categorized in Funding

   • OCT market set for rapid growth
   • also categorized in Funding
   • Optical Coherence Tomography Market To Top $800 Million By 2012
   • also categorized in Funding
   • Imalux Closes Series C Funding Round
   • also mentions Imalux Niris
   • Report identifies $200M OCT market
   • also categorized in Funding
   • Imalux Awarded $2.3 Million Research Grant
   • also categorized in Funding

Login to comment.